Axa’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-185,100
Closed -$3.77M 272
2025
Q2
$3.77M Buy
185,100
+297
+0.2% +$5.78K 0.01% 623
2025
Q1
$3.35M Sell
184,803
-237
-0.1% -$5.29K 0.01% 629
2024
Q4
$4.68M Sell
185,040
-294
-0.2% -$7.99K 0.01% 556
2024
Q3
$6.3M Buy
185,334
+43,044
+30% +$1.64M 0.02% 484
2024
Q2
$5.27M Buy
142,290
+81
+0.1% +$3.06K 0.02% 524
2024
Q1
$5.97M Buy
142,209
+39
+0% +$1.6K 0.02% 515
2023
Q4
$5.64M Sell
142,170
-3,439
-2% -$101K 0.02% 526
2023
Q3
$4.01M Buy
145,609
+31,479
+28% +$987K 0.01% 573
2023
Q2
$3.87M Buy
114,130
+1,570
+1% +$52.9K 0.01% 608
2023
Q1
$4.05M Sell
112,560
-259
-0.2% -$11.2K 0.01% 618
2022
Q4
$5.03M Sell
112,819
-46,400
-29% -$1.66M 0.02% 596
2022
Q3
$4.48M Buy
159,219
+31,403
+25% +$963K 0.02% 597
2022
Q2
$3.45M Sell
127,816
-27,107
-17% -$787K 0.01% 663
2022
Q1
$5.28M Sell
154,923
-3,999
-3% -$128K 0.02% 631
2021
Q4
$6.14M Sell
158,922
-4,061
-2% -$177K 0.02% 614
2021
Q3
$8.8M Sell
162,983
-65,968
-29% -$3.1M 0.02% 534
2021
Q2
$7.66M Sell
228,951
-68,832
-23% -$1.89M 0.02% 589
2021
Q1
$6.13M Buy
297,783
+287,283
+2,736% +$6.6M 0.02% 652
2020
Q4
$184K Buy
+10,500
New +$189K ﹤0.01% 1180
2018
Q2
Sell
-18,607
Closed -$650K 1354
2018
Q1
$650K Hold
18,607
﹤0.01% 1107
2017
Q4
$793K Sell
18,607
-13,983
-43% -$599K ﹤0.01% 1065
2017
Q3
$1.4M Buy
32,590
+7
+0% +$262 0.01% 893
2017
Q2
$1.21M Hold
32,583
0.01% 892
2017
Q1
$1.76M Buy
32,583
+13,860
+74% +$722K 0.01% 808
2016
Q4
$994K Buy
18,723
+490
+3% +$27.9K ﹤0.01% 908
2016
Q3
$1.1M Buy
+18,233
New +$1.14M ﹤0.01% 881
2015
Q3
Sell
-25,512
Closed -$9.65M 1456
2015
Q2
$9.65M Hold
25,512
0.04% 432
2015
Q1
$10.7M Buy
25,512
+1,801
+8% +$644K 0.04% 390
2014
Q4
$6.49M Buy
23,711
+1,228
+5% +$305K 0.03% 487
2014
Q3
$4.37M Buy
+22,483
New +$4.9M 0.02% 573

Other funds holding CLDX